Nombre de documents

27

CV de Agnès Fournier


Article dans une revue24 documents

  • Jean-Louis Marie, Thibaut Tronchin, Nathalie Grosjean, Loïc Méès, Onur Can Oztürk, et al.. Digital holographic measurement of the Lagrangian evaporation rate of droplets dispersing in a homogeneous isotropic turbulence. Experiments in Fluids, Springer Verlag (Germany), 2017, 58, pp.11. <10.1007/s00348-016-2292-8>. <hal-01447134>
  • Agnès Fournier, Sylvie Mesrine, Laure Dossus, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, et al.. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. Breast Cancer Research and Treatment, Springer Verlag, 2014, 145 (2), pp.535-43. <10.1007/s10549-014-2934-6>. <inserm-01319982>
  • Rebecca Ritte, Kaja Tikk, Annekatrin Lukanova, Anne Tjønneland, Anja Olsen, et al.. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.. BMC Cancer, BioMed Central, 2013, 13 (1), pp.584. <10.1186/1471-2407-13-584>. <inserm-00920375>
  • Rebecca Ritte, Annekatrin Lukanova, Franco Berrino, Laure Dossus, Anne Tjønneland, et al.. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.. Breast Cancer Research, BioMed Central, 2012, 14 (3), pp.R76. <10.1186/bcr3186>. <inserm-00704067>
  • Agnès Fournier, Céline Kernaleguen, Henri Panjo, Françoise Clavel-Chapelon, Virgine Ringa. Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts Running title: Evolution of HT use in France. Menopause, Lippincott, Williams & Wilkins, 2011, 18 (2), pp.219-23. <10.1097/gme.0b013e3181ecf3ec>. <inserm-01320290>
  • Marianne Canonico, Agnès Fournier, Laure Carcaillon, Valérie Olié, Geneviève Plu-Bureau, et al.. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.: Hormone therapy and venous thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2010, 30 (2), pp.340-5. <10.1161/ATVBAHA.109.196022>. <inserm-01142846>
  • Isabelle Romieu, Alban Fabre, Agnès Fournier, Francine Kauffmann, Raphaëlle Varraso, et al.. Postmenopausal hormone therapy and asthma onset in the E3N cohort.: Hormone therapy and asthma. Thorax, BMJ Publishing Group, 2010, 65 (4), pp.292-7. <10.1136/thx.2009.116079>. <inserm-00517871>
  • Blandine De Lauzon-Guillain, Agnès Fournier, Alban Fabre, Natalie Simon, Sylvie Mesrine, et al.. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.. Diabetologia, Springer Verlag, 2009, 52 (10), pp.2092-100. <10.1007/s00125-009-1456-y>. <inserm-00433479>
  • Agnès Fournier, Sylvie Mesrine, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon. Title: Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?: MHT and breast cancer according to timing of treatment initiation. Journal of Clinical Oncology, American Society of Clinical Oncology, 2009, 27 (31), pp.5138-43. <10.1200/JCO.2008.21.6432>. <inserm-01319999>
  • Agnès Fournier, Elisabete Weiderpass. Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women: MHT use evolution. Climacteric, Taylor & Francis, 2009, 12 (5), pp.410-418. <10.1080/13697130802716056>. <inserm-01320177>
  • Agnès Fournier, Alban Fabre, Sylvie Mesrine, Marie-Christine Boutron-Ruault, Franco Berrino, et al.. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.. Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (8), pp.1260-8. <10.1200/JCO.2007.13.4338>. <inserm-00271114>
  • Agnès Fournier, Franco Berrino, Françoise Clavel-Chapelon. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.. Breast Cancer Research and Treatment, Springer Verlag, 2008, 107 (1), pp.103-11. <10.1007/s10549-007-9523-x>. <inserm-00201813>
  • Séverine Sabia, Agnès Fournier, Sylvie Mesrine, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon. Risk factors for onset of menopausal symptoms: results from a large cohort study.. Maturitas, Elsevier, 2008, 60 (2), pp.108-21. <10.1016/j.maturitas.2008.04.004>. <inserm-01148002>
  • Alban Fabre, Agnès Fournier, Sylvie Mesrine, Joëlle Desreux, Anne Gompel, et al.. Oral progestagens before menopause and breast cancer risk.. Br J Cancer, 2007, 96 (5), pp.841-4. <10.1038/sj.bjc.6603618>. <inserm-00143656>
  • Marina Touillaud, Anne Thiébaut, Agnès Fournier, Maryvonne Niravong, Marie-Christine Boutron-Ruault, et al.. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.. JNCI Journal of the National Cancer Institute, 2007, 99 (6), pp.475-86. <10.1093/jnci/djk096>. <inserm-00148003>
  • Marina Kvaskoff, Sylvie Mesrine, Agnès Fournier, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon. Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women.. Archives of Internal Medicine, 2007, 167 (19), pp.2061-5. <10.1001/archinte.167.19.2061>. <inserm-00187690>
  • Marie-Noël Vercambre, Agnès Fournier, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Virginie Ringa, et al.. Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?. American Journal of Epidemiology, Oxford University Press (OUP), 2007, 166 (12), pp.1451-60. <10.1093/aje/kwm162>. <inserm-00170064>
  • Séverine Sabia, Agnès Fournier, Sylvie Mesrine, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon. Risk of onset of menopausal symptoms in periods surrounding menopause.. Maturitas, Elsevier, 2007, 58 (4), pp.340-7. <10.1016/j.maturitas.2007.09.012>. <inserm-00192649>
  • Sylvie Mesrine, Agnès Fournier, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon. Unsuspected consequences of the adolescent overweight epidemic.. Pediatrics, American Academy of Pediatrics, 2007, 120 (4), 924-5; author reply 925-6. <10.1542/peds.2007-1698>. <inserm-00193057>
  • John Danesh, Rodolfo Saracci, Göran Berglund, Edith Feskens, Kim Overvad, et al.. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries.. European Journal of Epidemiology, Springer Verlag, 2006, 22 (2), pp.129-41. <inserm-01149104>
  • Vanessa Dumeaux, Agnès Fournier, Eiliv Lund, Françoise Clavel-Chapelon. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.. Cancer Causes & Control, 2005, 16 (5), pp.537-44. <10.1007/s10552-004-8024-z>. <inserm-00147992>
  • Agnès Fournier, Franco Berrino, Elio Riboli, Valérie Avenel, Françoise Clavel-Chapelon. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.. Int J Cancer, 2005, 114 (3), pp.448-54. <10.1002/ijc.20710>. <inserm-00129104>
  • Agnès Fournier, Catherine Hill, Françoise Clavel-Chapelon. [Hormone replacement therapy in menopause and risk of breast cancer]. Bulletin du Cancer, John Libbey Eurotext, 2003, 90 (10), pp.821-31. <inserm-00170282>
  • Agnès Fournier, Françoise Clavel-Chapelon, Catherine Hill. [Menopause hormonal treatment and risk of breast cancer: comments on the results of the Million Women Study]. Bulletin du Cancer, John Libbey Eurotext, 2003, 90 (10), pp.924-6. <inserm-00168642>

Communication dans un congrès2 documents

  • Blandine De Lauzon-Guillain, Agnès Fournier, Alban Fabre, Nicolas Simon, Sylvie Mesrine, et al.. Traitement hormonal de la ménopause et risque de diabète chez les femmes de la cohorte E3N. ALFEDIAM, Mar 2009, Strasbourg, France. 35 (supplement 1), pp.A9, 2009. <inserm-00375813>
  • Marianne Canonico, Agnès Fournier, Laure Carcaillon, Valérie Olié, Geneviève Plu-Bureau, et al.. Hormone Therapy and Venous Thromboembolism: Early Results from the E3N Prospective Study. Nutrition, Physical Activity, Metabolism Conference 2008, Mar 2008, Colorado Spring, United States. <inserm-00289239>

Autre publication1 document

  • Agnès Fournier, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon. Breast cancer and hormonal therapy in postmenopausal women. Letter to the editors. 2009, <10.1056/NEJMc090490>. <inserm-01320254>